Home » Topics » Regulatory

Regulatory
RSS

DuPont Merck's breast imaging agent approved in the U.K.

June 18, 1997

RPR seeks approval for enoxaparin for unstable angina in Europe

June 18, 1997

New vial size of generic leucovorin approved by FDA

June 17, 1997

Botulinum toxin type A evaluated in cerebral palsy

June 16, 1997

Oral human immunoglobulin enters clinic for severe RA

June 13, 1997

Testosterone transdermal patch now available in the U.S. in a once-daily formulation

June 13, 1997

Carvedilol and its metabolite attenuate Hb-mediated neuronal injury

June 13, 1997

ACE inhibitors for diabetes

June 13, 1997

Mylan files ANDA for generic nifedipine

June 12, 1997

Transdermal buspirone patch shows encouraging results in ADHD

June 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.